143 related articles for article (PubMed ID: 19783640)
1. Microbial exposure early in life regulates airway inflammation in mice after infection with Streptococcus pneumoniae with enhancement of local resistance.
Yasuda Y; Matsumura Y; Kasahara K; Ouji N; Sugiura S; Mikasa K; Kita E
Am J Physiol Lung Cell Mol Physiol; 2010 Jan; 298(1):L67-78. PubMed ID: 19783640
[TBL] [Abstract][Full Text] [Related]
2. Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae.
Hong JS; Greenlee KJ; Pitchumani R; Lee SH; Song LZ; Shan M; Chang SH; Park PW; Dong C; Werb Z; Bidani A; Corry DB; Kheradmand F
J Immunol; 2011 Jun; 186(11):6427-36. PubMed ID: 21508260
[TBL] [Abstract][Full Text] [Related]
3. Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae.
Akahori Y; Miyasaka T; Toyama M; Matsumoto I; Miyahara A; Zong T; Ishii K; Kinjo Y; Miyazaki Y; Saijo S; Iwakura Y; Kawakami K
BMC Immunol; 2016 Jan; 17():1. PubMed ID: 26727976
[TBL] [Abstract][Full Text] [Related]
4. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.
Hare KM; Smith-Vaughan HC; Chang AB; Pizzutto S; Petsky HL; McCallum GB; Leach AJ
Vaccine; 2017 Feb; 35(5):747-756. PubMed ID: 28062125
[TBL] [Abstract][Full Text] [Related]
5. Allergic airway inflammation disrupts interleukin-17 mediated host defense against streptococcus pneumoniae infection.
Guo S; Wu LX; Jones CX; Chen L; Hao CL; He L; Zhang JH
Int Immunopharmacol; 2016 Feb; 31():32-8. PubMed ID: 26699848
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
[TBL] [Abstract][Full Text] [Related]
7. Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice.
Clement CG; Tuvim MJ; Evans CM; Tuvin DM; Dickey BF; Evans SE
Respir Res; 2009 Jul; 10(1):70. PubMed ID: 19635139
[TBL] [Abstract][Full Text] [Related]
8. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection.
Wang J; Barke RA; Charboneau R; Roy S
J Immunol; 2005 Jan; 174(1):426-34. PubMed ID: 15611267
[TBL] [Abstract][Full Text] [Related]
9. IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia.
Kovach MA; Singer B; Martinez-Colon G; Newstead MW; Zeng X; Mancuso P; Moore TA; Kunkel SL; Peters-Golden M; Moore BB; Standiford TJ
Mucosal Immunol; 2017 Sep; 10(5):1320-1334. PubMed ID: 28176791
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-23 (IL-23) deficiency disrupts Th17 and Th1-related defenses against Streptococcus pneumoniae infection.
Kim BJ; Lee S; Berg RE; Simecka JW; Jones HP
Cytokine; 2013 Oct; 64(1):375-81. PubMed ID: 23752068
[TBL] [Abstract][Full Text] [Related]
11. R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae.
Hoogendijk AJ; Roelofs JJ; Duitman J; van Lieshout MH; Blok DC; van der Poll T; Wieland CW
Mol Med; 2012 Sep; 18(1):1086-95. PubMed ID: 22692577
[TBL] [Abstract][Full Text] [Related]
12. The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice.
Stegenga ME; Florquin S; de Vos AF; van der Poll T
Crit Care Med; 2009 Feb; 37(2):614-8. PubMed ID: 19114898
[TBL] [Abstract][Full Text] [Related]
13.
Sharma-Chawla N; Stegemann-Koniszewski S; Christen H; Boehme JD; Kershaw O; Schreiber J; Guzmán CA; Bruder D; Hernandez-Vargas EA
Front Immunol; 2019; 10():1864. PubMed ID: 31474978
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal pneumonia suppresses allergy development but preserves respiratory tolerance in mice.
Hartmann C; Behrendt AK; Henken S; Wölbeling F; Maus UA; Hansen G
Immunol Lett; 2015 Mar; 164(1):44-52. PubMed ID: 25576460
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.
Rijneveld AW; Levi M; Florquin S; Speelman P; Carmeliet P; van Der Poll T
J Immunol; 2002 Apr; 168(7):3507-11. PubMed ID: 11907112
[TBL] [Abstract][Full Text] [Related]
16. Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.
Hergott CB; Roche AM; Naidu NA; Mesaros C; Blair IA; Weiser JN
J Clin Invest; 2015 Oct; 125(10):3878-90. PubMed ID: 26426079
[TBL] [Abstract][Full Text] [Related]
17. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.
Albiger B; Sandgren A; Katsuragi H; Meyer-Hoffert U; Beiter K; Wartha F; Hornef M; Normark S; Normark BH
Cell Microbiol; 2005 Nov; 7(11):1603-15. PubMed ID: 16207247
[TBL] [Abstract][Full Text] [Related]
18. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.
Dubin PJ; Kolls JK
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L519-28. PubMed ID: 17071720
[TBL] [Abstract][Full Text] [Related]
19. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis.
Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T
Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906
[TBL] [Abstract][Full Text] [Related]
20. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
